Antibody-based profiling of cerebrospinal fluid within multiple sclerosis

Area of Science:

• Neuroscience
• Biochemistry
• Immunology

Background:

• Antibody suspension bead arrays facilitate high-throughput protein profiling in biological fluids.
• Cerebrospinal fluid (CSF) analysis is crucial for diagnosing neurological disorders.
• Existing protein profiling methods for CSF face challenges with inherent sample variations.

Purpose of the Study:

• To develop and validate a robust protein profiling assay for human cerebrospinal fluid (CSF).
• To identify potential protein biomarkers for multiple sclerosis (MS) using CSF.
• To optimize assay conditions for accurate and sensitive CSF protein analysis.

Main Methods:

• Development of a direct labeling antibody suspension bead array assay for CSF.
• Optimization of the assay by supplementing with Bovine Serum Albumin (BSA) and Immunoglobulin G (IgG) to normalize intensity differences.
• Assessment of heat treatment effects on CSF protein analysis.
• Profiling of 43 proteins using 101 antibodies in 339 CSF samples from MS patients and controls.

Main Results:

• Supplementation with BSA and IgG reduced sample-specific total protein amount variations without compromising assay sensitivity.
• Two proteins, GAP43 and SERPINA3, demonstrated differential expression levels in CSF.
• GAP43 levels were lower in secondary progressive MS compared to early MS and other neurological diseases.
• SERPINA3 levels were elevated in all MS patients compared to controls.

Conclusions:

• The developed assay provides a reliable method for broad-scale CSF protein profiling in neurological disorders.
• GAP43 and SERPINA3 show promise as potential biomarkers for MS.
• This assay enhances the potential for discovering novel CSF biomarkers for various neurological conditions.